Skip to content

CANIVET RAYS: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CANIVET RAYS

BE 1008.482.175
NACE 86.220, Specialist medical practice
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€17,584
2024 · €24,978-€7,395
Equity
€45,062
2024 · €27,478+€17,584
Cash
€19,674
2024 · €23,846-€4,172
Balance sheet total
€52,551
2024 · €33,631+€18,920

Largest movements

2024 to 2025
Assets
  • Current investments +€30,000

    new in 2025: €30,000

  • Deferred charges and accrued income -€6,994

    down €6,994 (-81.9%), from €8,535 to €1,541

  • Cash -€4,172

    down €4,172 (-17.5%), from €23,846 to €19,674

    mainly Current investments (-€30,000) and Trade debts (-€1,415)

Equity and liabilities
  • Profit (loss) carried forward +€17,584

    up €17,584 (+70.4%), from €24,978 to €42,562

  • Other debts +€2,494

    up €2,494 (+1649.6%), from €151 to €2,645

  • Trade debts -€1,415

    down €1,415 (-89.7%), from €1,577 to €162

Income statement
  • Gross operating margin -€9,092

    down €9,092 (-28.8%), from €31,584 to €22,491

  • Taxes -€1,742

    down €1,742 (-27.1%), from €6,424 to €4,682

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €24,978
Gross operating margin -€9,092
Other operating charges +€27
Financial charges -€72
Taxes +€1,742
Result 2025 €17,584

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€25,828
Investment -€30,000
Financing €0
Cash 2024 €23,846
Net result for the year +€17,584
Receivables within one year -€86
Deferred charges and accrued income +€6,994
Trade debts -€1,415
Tax, wage and social debts +€258
Other debts +€2,494
Current investments -€30,000
Cash 2025 €19,674
Every line side by side 27 lines
Line Code 2024 2025 Change %
Total assets 20/58 €33,631 €52,551 +€18,920 +56.3%
Current assets 29/58 €33,631 €52,551 +€18,920 +56.3%
Amounts receivable within one year 40/41 €1,250 €1,336 +€86 +6.9%
Trade receivables 40 €1,250 €1,336 +€86 +6.9%
Current investments 50/53 - €30,000 +€30,000
Cash at bank and in hand 54/58 €23,846 €19,674 -€4,172 -17.5%
Deferred charges and accrued income 490/1 €8,535 €1,541 -€6,994 -81.9%
Total equity and liabilities 10/49 €33,631 €52,551 +€18,920 +56.3%
Equity 10/15 €27,478 €45,062 +€17,584 +64.0%
Contributions 10/11 €2,500 €2,500 = 0.0%
Profit (loss) carried forward 14 €24,978 €42,562 +€17,584 +70.4%
Amounts payable 17/49 €6,153 €7,489 +€1,336 +21.7%
Amounts payable within one year 42/48 €6,153 €7,489 +€1,336 +21.7%
Trade debts 44 €1,577 €162 -€1,415 -89.7%
Suppliers 440/4 €1,577 €162 -€1,415 -89.7%
Taxes, remuneration and social security 45 €4,424 €4,682 +€258 +5.8%
Taxes 450/3 €4,424 €4,682 +€258 +5.8%
Other amounts payable 47/48 €151 €2,645 +€2,494 +1649.6%
Other operating charges 640/8 €127 €100 -€27 -21.2%
Gross operating margin 9900 €31,584 €22,491 -€9,092 -28.8%
Operating profit (loss) 9901 €31,457 €22,392 -€9,065 -28.8%
Financial charges 65/66B €54 €126 +€72 +132.0%
Recurring financial charges 65 €54 €126 +€72 +132.0%
Profit (loss) for the period before taxes 9903 €31,403 €22,266 -€9,137 -29.1%
Income taxes 67/77 €6,424 €4,682 -€1,742 -27.1%
Profit (loss) for the period 9904 €24,978 €17,584 -€7,395 -29.6%
Profit (loss) for the period to be appropriated 9905 €24,978 €17,584 -€7,395 -29.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.